Overview / Abstract: |
Target Audience Activity Overview In this on-demand, online CME activity, two faculty experts in choroideremia and gene therapy discuss the pathophysiology, diagnosis, and emerging treatments for CHM. In their discussion, they share their experiences in caring for patients with choroideremia, giving learners practical insights into this rare disease. Their firsthand experience with clinical trials sheds new light on the potential role of emerging gene therapies in the treatment of this disease. Learning Objectives Discuss the role of the CHM gene in the pathophysiology of choroideremia |
Expiration |
Mar 22, 2022 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
1.5 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
M. Dominik Fischer, MD, PhD, FEBO |
Sponsors / Supporters / Grant Providers |
Biogen |
Keywords / Search Terms |
Relias LLC Relias, Free CME, Choroideremia, Gene Therapy Free CE CME |